Skip to main content

Novartis has got one more winner

Tasigna has got fast-track approval from the FDA to be used to treat Ph+ chronic phase CML (chronic myeloid leukemia).

To use the technical phrase, the FDA has approved a new indication for Tasigna (nilotinib) for the treatment of CML.

This new indication expands the use of Tasigna to to adult patients in earlier stages of the disease.

The new indication for Tasigna was approved under the FDA's accelerated approval program, which allows FDA to approve a drug to treat serious diseases with an unmet medical need based on an endpoint thought to reasonably predict clinical benefit.

The interesting thing is that while the FDA has approved the drug, in the meanwhile, the company is required to collect additional long term efficacy and safety data confirming the drug's benefit.

Thus, with this accelerated approval program, patients get to lay their hands on promising new drugs while the confirmatory clinical trials are being conducted.

One can hope that these confirmatory trials will stand transparent scrutiny and no inconvenient data will be hidden under the carpet on account of Big Pharma greed.

So, Novartis now provides the one-two punch for CML so to say: Gleevec and Tasigna.

Comments

Popular posts from this blog

Longforms and 'Best of 2017' Lists and Favorite Books by Ashutosh Joglekar and Scott Aaronson

Ashutosh Joglekar's books list. http://wavefunction.fieldofscience.com/2018/03/30-favorite-books.html Scott Aaronson' list https://www.scottaaronson.com/blog/?p=3679 https://www.wired.com/story/most-read-wired-magazine-stories-2017/ https://www.theatlantic.com/entertainment/archive/2017/12/the-best-books-we-read-in-2017/548912/ https://longreads.com/2017/12/21/longreads-best-of-2017-essays/ https://www.nytimes.com/interactive/2017/12/21/world/asia/how-the-rohingya-escaped.html https://www.smithsonianmag.com/history/how-journalists-covered-rise-mussolini-hitler-180961407/ https://www.smithsonianmag.com/innovation/artificial-intelligence-future-scenarios-180968403/ https://www.newyorker.com/magazine/1997/01/20/citizen-kay https://www.smithsonianmag.com/innovation/where-we-are-hunt-cancer-vaccine-180968391/ https://www.smithsonianmag.com/innovation/dna-based-attack-against-cancer-may-work-180968407/ https://www.politico.com/magazine/story/2017/12/22/dona

Savita Bhabi

Well, it seems the Government of India is up to its usual censoring ways ... http://online.wsj.com/article/SB126327347865425871.html?mod=WSJ_hp_us_mostpop_read It's not as bad as what the Chinese are doing in battling Google. The Internet is awash in pornography and the feeble attempts of the Govt. of India won't be able to stem the tide. The Govt. should merely restrict itself to ensuring that there's no child pornography or trafficking of humans. There are problems galore for the Govt. to worry about as it is ...